Jane Street’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.1K Sell
11,900
-4,900
-29% -$15.5K ﹤0.01% 11134
2025
Q4
$67.2K Sell
16,800
-28,400
-63% -$158K ﹤0.01% 10387
2025
Q3
$382K Sell
45,200
-9,400
-17% -$91.2K ﹤0.01% 8414
2025
Q2
$615K Buy
+54,600
New +$501K ﹤0.01% 6542
2025
Q1
Sell
-143,200
Closed -$1.61M 9717
2024
Q4
$1.61M Sell
143,200
-136,500
-49% -$2.4M ﹤0.01% 4502
2024
Q3
$7.91M Buy
+279,700
New +$7.21M ﹤0.01% 2184
2024
Q1
Sell
-27,100
Closed -$895K 9426
2023
Q4
$895K Buy
27,100
+1,700
+7% +$48.1K ﹤0.01% 5747
2023
Q3
$692K Buy
25,400
+100
+0.4% +$2.78K ﹤0.01% 5753
2023
Q2
$767K Buy
25,300
+7,600
+43% +$246K ﹤0.01% 5656
2023
Q1
$574K Sell
17,700
-400
-2% -$12.6K ﹤0.01% 6092
2022
Q4
$508K Sell
18,100
-121,300
-87% -$3.48M ﹤0.01% 6113
2022
Q3
$5.01M Buy
139,400
+55,400
+66% +$1.95M ﹤0.01% 2612
2022
Q2
$2.58M Buy
84,000
+2,200
+3% +$64.1K ﹤0.01% 3708
2022
Q1
$2.64M Buy
81,800
+25,300
+45% +$662K ﹤0.01% 4220
2021
Q4
$1.56M Sell
56,500
-7,200
-11% -$207K ﹤0.01% 4980
2021
Q3
$1.98M Buy
63,700
+8,700
+16% +$209K ﹤0.01% 4507
2021
Q2
$1.16M Buy
+55,000
New +$1.1M ﹤0.01% 5509
2021
Q1
Sell
-10,300
Closed -$165K 9218
2020
Q4
$165K Buy
+10,300
New +$136K ﹤0.01% 7039

Other funds holding EVH

Jane Street's EVH Position: Q1 2026 in Review

Jane Street reduced its Evolent Health (EVH) stake by 39% in Q1 2026, selling an estimated $3.69M and leaving 1,790,147 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3815.

Jane Street first reported a position in EVH in Q1 2017 and has held it in 28 quarters since. The position peaked at $12.2M in Q3 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Jane Street held 1,790,147 shares of Evolent Health worth $4.08M as of Q1 2026.
  • Jane Street sold 1,162,800 Evolent Health shares in Q1 2026, an estimated $3.69M.
  • Evolent Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3815 holding.
  • Jane Street first reported a position in Evolent Health in Q1 2017 and has held it in 28 quarters since.
  • Jane Street's Evolent Health position peaked at $12.2M in Q3 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.